Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Justice

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
Annals of Internal Medicine|July 5, 2021
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational StudyJessie K Edwards, Stephen R Cole, Tiffany L Breger, et al.
American Journal of Epidemiology|August 5, 2011
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north americaAlison G Abraham, Bryan Lau, Steven Deeks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries, Lauren E Cain, Andrew Phillips, et al.
AIDS (London, England)|September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals, Maile Ray, Roger Logan, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
Medicine|October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individualsLauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.
Plos One|December 25, 2013
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaHasina Samji, Angela Cescon, Robert S Hogg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
Annals of Internal Medicine|July 5, 2021
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational StudyJessie K Edwards, Stephen R Cole, Tiffany L Breger, et al.
American Journal of Epidemiology|August 5, 2011
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north americaAlison G Abraham, Bryan Lau, Steven Deeks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries, Lauren E Cain, Andrew Phillips, et al.
AIDS (London, England)|September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals, Maile Ray, Roger Logan, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
Medicine|October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individualsLauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.
Plos One|December 25, 2013
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaHasina Samji, Angela Cescon, Robert S Hogg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Pageof 11